E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers G > Headlines for Glenmark Pharmaceuticals Ltd. > News item
Published on 7/27/2009 in the Prospect News Convertibles Daily.

Glenmark Pharmaceuticals OKs up to $250 million convertible bonds

By Devika Patel

Knoxville, Tenn., July 27 - Glenmark Pharmaceuticals Ltd. notified the Bombay Stock Exchange that it approved plans to issue up to $250 million of foreign currency convertible bonds at a board of directors' meeting on July 27.

Securities may also include Global Depositary Receipts, American Depositary Receipts and equity shares.

Glenmark Pharmaceuticals is a Mumbai, India, pharmaceutical company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.